V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 10003755 | 10006499 | null | 73.5 | Neo-adjuvant (N) | 2016-09-05 | 2016-09-19 | Fluorouracil + Folinic Acid Weekly | N | Y | 10488199 | FLUOROURACIL |
| 10003756 | 10006499 | 1.82 | null | Adjuvant (A) | 2016-07-14 | 2016-07-15 | Cisplatin 7 day | 2 | N | 10488199 | BCG |
| 10003757 | 10006499 | 1.68 | 87.4 | Disease modification (D) | 2018-07-29 | 2018-08-04 | Cisplatin + Etoposide (3 day) | 02 | N | 10488199 | CISPLATIN |
| 10003758 | 10002372 | null | 95.9 | Palliative (P) | 2017-09-06 | 2017-09-16 | Bortezomib +/- Dexamethasone | 02 | N | 10488480 | TEMOZOLOMIDE + RT |
| 10003759 | 10008126 | 1.8 | 89.6 | Adjuvant (A) | 2018-05-28 | 2018-06-11 | FLUOROURACIL | N | N | 10488501 | FLUOROURACIL |
| 10003760 | 10002373 | 1.58 | 70.5 | null | null | 2018-09-20 | CTD | N | N | 10488503 | PACLITAXEL |
| 10003761 | 10002373 | 1.6 | 86 | Adjuvant (A) | 2016-08-19 | 2016-09-18 | FEC + DOCETAXEL | N | N | 10488503 | FEC + DOCETAXEL |
| 10003762 | 10002374 | 1.78 | 60 | Adjuvant (A) | null | 2015-04-26 | CHOP - 21 days | N | N | 10488658 | BCG |
| 10003763 | 10002374 | null | null | Disease modification (D) | 2018-03-18 | 2018-03-18 | PACLITAXEL | N | N | 10488658 | CVD |
| 10003764 | 10008127 | null | null | Neo-adjuvant (N) | 2013-12-15 | 2013-12-23 | ABVD | N | N | 10488696 | BORTEZOMIB |
| 10003765 | 10008127 | 1.7 | 82 | Palliative (P) | 2018-03-12 | 2018-03-14 | EC | 02 | N | 10488696 | PACLITAXEL |
| 10003766 | 10002375 | 1.8 | 62 | null | 2018-01-07 | 2018-01-07 | Imatinib 400mg | 02 | N | 10488762 | CAPECITABINE + CISPLATIN |
| 10003767 | 10002376 | 1.73 | 95.2 | Palliative (P) | 2018-06-01 | 2018-06-08 | Paclitaxel 7 day | N | N | 10488810 | BORTEZOMIB |
| 10003768 | 10002377 | 1.78 | 86.81 | Adjuvant (A) | 2018-08-07 | 2018-08-07 | EC | N | N | 10488840 | EC |
| 10003769 | 10002378 | 0 | 89 | Neo-adjuvant (N) | 2017-10-04 | 2017-10-04 | FLUOROURACIL | 2 | N | 10488841 | FLUOROURACIL |
| 10003770 | 10002379 | 1.83 | 85 | Palliative (P) | 2019-02-20 | 2019-02-22 | Irinotecan + Modified De Gramont | 2 | N | 10488889 | IRINOTECAN + MDG |
| 10003771 | 10002380 | 1.74 | 75.3 | Palliative (P) | 2017-12-25 | 2017-12-28 | Bortezomib +/- Dexamethasone | N | N | 10488973 | CVD |
| 10003772 | 10002380 | 1.53 | null | null | 2016-01-02 | 2016-01-15 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 10488973 | EC |
| 10003773 | 10002380 | 1.57 | 55.9 | Adjuvant (A) | 2015-10-04 | 2015-10-04 | ABVD | N | N | 10488973 | CHLORAMBUCIL |
| 10003774 | 10002381 | 1.87 | null | Neo-adjuvant (N) | 2017-11-07 | 2017-11-10 | Capecitabine 35days + RT | 02 | Y | 10489029 | CAPECITABINE + RT |
| 10003775 | 10002382 | 0 | 66.7 | Adjuvant (A) | null | 2016-09-28 | CISPLATIN + ETOPOSIDE | N | N | 10489036 | CTD |
| 10003776 | 10002383 | 1.73 | 96.9 | Adjuvant (A) | 2016-11-03 | 2016-11-07 | Fluorouricil + Folonic Acid (MdG) | N | N | 10489038 | FLUOROURACIL |
| 10003777 | 10002384 | 0 | 80.8 | Curative (C) | 2017-10-13 | 2017-10-21 | Abiraterone | 2 | N | 10489054 | IMATINIB |
| 10003778 | 10002384 | 1.75 | 84.5 | Disease modification (D) | 2017-12-16 | 2018-01-04 | Bortezomib +/- Dexamethasone | N | N | 10489054 | PACLITAXEL |
| 10003779 | 10002384 | 1.73 | 68 | Curative (C) | 2017-12-19 | 2017-12-24 | Cisplatin 100 + RT(H&N) 1 day | N | N | 10489054 | CISPLATIN + RT |
| 10003780 | 10002384 | null | null | Disease modification (D) | null | 2018-07-28 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 10489054 | CHOP |
| 10003781 | 10002384 | 1.66 | null | Palliative (P) | 2016-02-12 | 2016-03-02 | Irinotecan + Modified De Gramont | 02 | N | 10489054 | IRINOTECAN + MDG |
| 10003782 | 10002385 | 1.74 | 84 | Palliative (P) | 2017-04-22 | 2017-04-22 | Bortezomib +/- Dexamethasone | 2 | N | 10489172 | BORTEZOMIB |
| 10003783 | 10002386 | null | 68.3 | null | 2016-08-04 | 2016-08-08 | Bortezomib + CYCLOPHOSPHAMIDE | N | N | 10489184 | ABVD |
| 10003784 | 10006504 | null | null | Disease modification (D) | 2017-05-29 | 2017-06-12 | Azacitidine | N | N | 10489221 | CHLORAMBUCIL |
| 10003785 | 10002387 | 1.6 | 0 | Palliative (P) | 2017-02-25 | 2017-02-25 | Irinotecan + Modified De Gramont | N | N | 10489239 | IRINOTECAN + MDG |
| 10003786 | 10006505 | 0 | 102.1 | Disease modification (D) | 2013-10-09 | 2013-10-11 | Bortezomib +/- Dexamethasone | N | N | 10489240 | CHOP |
| 10003787 | 10002388 | 1.46 | 88.4 | Disease modification (D) | 2015-12-18 | 2016-01-08 | Azacitidine | N | N | 10489253 | CAPECITABINE + CISPLATIN |
| 10003788 | 10002388 | 1.6 | 0 | Disease modification (D) | 2017-08-30 | 2017-08-31 | Bortezomib + Cyclophos + Dex | 2 | N | 10489253 | BCG |
| 10003789 | 10002389 | 1.73 | 92 | Curative (C) | 2018-01-27 | 2018-02-22 | Azacitidine | 02 | Y | 10489263 | CISPLATIN + ETOPOSIDE |
| 10003790 | 10002390 | 1.59 | 53 | null | 2017-05-30 | 2017-06-06 | Chlorambucil | 02 | null | 10489316 | CAPECITABINE + CISPLATIN |
| 10003791 | 10002391 | 1.67 | 78.4 | Palliative (P) | 2018-07-14 | 2018-08-01 | Bortezomib + Cyclophos + Dex | N | N | 10489323 | IMATINIB |
| 10003792 | 10006507 | 1.55 | 53.2 | Adjuvant (A) | 2017-01-12 | 2017-01-22 | Cisplatin 7 day | N | N | 10489367 | FLUOROURACIL + MITOMYCIN + RT |
| 10003793 | 10002392 | 1.63 | 86 | Adjuvant (A) | 2016-10-08 | 2016-10-08 | FEC 60 OR 75 + DOCETAXEL | 02 | N | 10489385 | FEC + DOCETAXEL |
| 10003794 | 10002392 | 1.78 | 69 | Adjuvant (A) | 2016-06-09 | 2016-06-09 | Bortezomib + CYCLOPHOSPHAMIDE | 2 | N | 10489385 | IMATINIB |
| 10003795 | 10002392 | 1.7 | 94 | Neo-adjuvant (N) | 2017-12-01 | 2017-12-01 | EC | 2 | N | 10489385 | BCG |
| 10003796 | 10006509 | 1.8 | 70 | Adjuvant (A) | 2017-10-14 | 2017-10-15 | FEC + DOCETAXEL | N | N | 10489425 | FEC + DOCETAXEL |
| 10003797 | 10002393 | 1.73 | null | Curative (C) | 2016-08-16 | 2016-08-19 | CYCLOPHOSPHAMIDE + THALIDOMIDE | 99 | N | 10489455 | FLUOROURACIL + MITOMYCIN + RT |
| 10003798 | 10002394 | null | 71.3 | Curative (C) | 2016-11-11 | 2016-11-20 | CHOP - 21 days | N | N | 10489481 | BCG |
| 10003799 | 10002395 | 1.6 | 66 | Curative (C) | 2018-02-02 | 2018-03-03 | Temozolomide + RT | N | Y | 10489503 | CHOP |
| 10003800 | 10002396 | 1.84 | 55.8 | Curative (C) | 2015-10-21 | 2015-10-25 | Chlorambucil | N | N | 10489505 | CAPECITABINE + GEMCITABINE |
| 10003801 | 10002397 | 1.77 | 70.6 | Curative (C) | 2016-10-07 | 2016-10-16 | Fluorouracil+Mitomycin+RT (Anal Ca) | N | N | 10489526 | IMATINIB |
| 10003802 | 10002397 | 1.6 | 70.4 | Adjuvant (A) | 2018-05-15 | 2018-07-03 | BCG Intravesical | N | N | 10489526 | ABVD |
| 10003803 | 10002398 | 1.77 | 87.5 | Curative (C) | 2015-09-30 | 2015-10-07 | Chlorambucil | 02 | N | 10489599 | IMATINIB |
| 10003804 | 10002398 | 1.69 | 72 | null | 2018-10-30 | 2018-10-31 | ABVD | 2 | N | 10489599 | FLUOROURACIL + MITOMYCIN + RT |